Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Propanc Biopharma Inc PPCB

Healthcare Biotechnology
Propanc Biopharma, Inc. is an Australia-based clinical biopharmaceutical company. The Company is focused on the development of novel cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. The Company has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from... see more

Recent & Breaking News (OTCPK:PPCB)

Day 6 of the Shanghai Saga-Time To Make a Shopping List of Cheap Stocks to Buy (4 Stocks)

Accesswire August 27, 2015

The NASDAQ Biotech Index Is Partying Like It's 1999 - Some Say The Party's Just Getting Started, Some Say We're At The Top

Accesswire August 24, 2015

Propanc Identifies Potential Patent Opportunities

Accesswire August 13, 2015

Propanc Identifies Potential Patent Opportunities

Accesswire August 13, 2015

Propanc Up-lists to OTCQB; Reduces Authorized Shares by 80%

Accesswire August 4, 2015

Propanc Up-lists to OTCQB; Reduces Authorized Shares by 80%

Accesswire August 4, 2015

Propanc Identifies Positive Signals for Efficacy from Pilot Animal Studies

Accesswire July 9, 2015

Propanc Enters into Research Agreement with Adaptive Biotechnologies

Accesswire July 6, 2015

Propanc Enters into Research Agreement with Adaptive Biotechnologies

Accesswire July 6, 2015

The Wealthy Biotech Trader's New Feature Pick Runs Over 150% After Announcement - Traders are Calling it the Next PPCH 3,200%+ Runner

Accesswire June 25, 2015

Boehringer Ingelheim Executive Joins Propanc's Scientific Advisory Board

Accesswire June 22, 2015

Propanc Provides Shareholder Update

Accesswire June 19, 2015

Propanc Provides Shareholder Update

Accesswire June 19, 2015

Propanc Settles Two Outstanding Convertible Debts

Accesswire June 18, 2015

Propanc Settles Two Outstanding Convertible Debts

Accesswire June 18, 2015

Three Companies with the Ingredients to Follow in the Footsteps of Advaxis (NASDAQ: ADXS)

Accesswire June 16, 2015

Propanc Briefs Investors at the SeeThruEquity 4th Annual Investor Conference

Accesswire May 29, 2015

SeeThruEquity Initiates Coverage on Propanc Health Group with a Price Target of $1.52

Accesswire May 27, 2015

Corrected Article - The Road To The Cure: 4 Biotech Stocks Advancing New Therapies In The Fight Against Cancer

Accesswire May 19, 2015

The Road To The Cure: 4 Biotech Stocks Advancing New Therapies In The Fight Against Cancer

Accesswire May 17, 2015